Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
United Therapeutics Chief Financial Officer and Treasurer Edgemond James sold $5.36 million of company stock on March 26, 2026, while exercising stock options for 10,000 shares the same day. The trades were executed under a Rule 10b5-1 plan. The company has also announced a $2 billion repurchase program and reported that its phase 3 TETON-2 study o…
Tyra Biosciences director Gilla Kaplan executed a series of option exercises and subsequent stock sales on March 25-26, 2026, realizing proceeds of roughly $2.54 million while retaining a stake in the company. The transactions coincide with a recent block sale of 4,000,000 shares that raised $126 million for the company and with sustained analyst s…
Kimberly D. Campos, who serves as Chief Information Officer and Chief Accounting Officer at Universal Insurance Holdings, sold 879 shares on March 26, 2026, realizing $29,745. The company recently reported fourth-quarter 2025 results that included an EPS of $2.17, materially above analyst expectations, while revenue came in marginally below forecas…
Okta Chief Revenue Officer Jonathan James Addison sold 23,304 shares of Class A common stock on March 25, 2026, for about $1.8 million under a pre-established Rule 10b5-1 plan. The trades took place at prices between $77.1011 and $78.653 per share. The stock's market quote sits at $73.21, near a 52-week low of $68.77, while InvestingPro’s Fair Valu…
Sean P. Downes, Executive Chairman of Universal Insurance Holdings (NASDAQ: UVE), sold 20,000 shares on March 25, 2026, for $692,072 at a weighted average price of $34.6036. The transaction occurred as the stock trades at a P/E of 5.34 and has returned 53% over the past year. Universal Insurance reported fourth-quarter 2025 EPS of $2.17, well ahead…
Karen Sykes, President and CMO of DD'S DISCOUNTS at Ross Stores, sold 5,506 shares on March 25, 2026, for $213.4006 per share, a transaction valued at $1,174,983. The sale occurred while the share price trades close to a 52-week high and after the company reported better-than-expected fourth-quarter fiscal 2025 results and signalled an aggressive s…
Cardinal Infrastructure Group Inc. (NASDAQ: CDNL) director Zelman Ivy purchased 6,921 shares on March 26, 2026, at a weighted average price of $36.33, a transaction totaling $251,439. The trade occurred as the stock trades near its 52-week high and follows robust quarterly revenue growth and a regional leadership appointment.
Manhattan Bridge Capital, Inc., a Nasdaq-listed firm specializing in short-term secured real estate loans, reported net income of approximately $5.11 million for 2025, down 8.6% from 2024 due to lower interest income and a decrease in loan originations. Revenue declined by 10.6% reflecting a contraction in loans receivable and slowed loan originati…
Biodexa Pharmaceuticals PLC, a NASDAQ-listed clinical-stage biopharmaceutical company specializing in gastrointestinal cancers, announced its audited preliminary results for the year ended December 31, 2025. Key developments include progress in the Phase 3 Serenta trial of eRapa for Familial Adenomatous Polyposis, initiation of a Phase 2a study of …
A federal judge has permitted two class-action lawsuits to proceed against Colgate-Palmolive, concluding that the company’s mouth rinse packaging may mislead parents into believing the products are safe for children under six. A separate claim over Colgate toothpaste was dismissed because its labeling included explicit instructions for young childr…
BKV Corp Chief Financial Officer David Tameron sold 7,300 shares of common stock on March 27, 2026, in multiple transactions that averaged $29.71 per share. The sale, executed under a pre-established Rule 10b5-1 trading plan, raised $216,918 and leaves Tameron with 61,925 shares. The transaction comes as BKV reports solid fourth-quarter results, an…
Yesway has refiled for a U.S. initial public offering, reviving plans it suspended in late 2022. The Fort Worth, Texas-based convenience store operator reported stronger profitability and higher revenue year-over-year and intends to list on the Nasdaq under the ticker YSWY. The filing comes as global market volatility and U.S. consumer affordabilit…
Director Charles Thomas McMillen sold 30,000 shares of Castellum, Inc. (OTC:CTM) on March 25, 2026, for $21,129, according to a Form 4 filing. The transaction follows a recent share-price decline and leaves McMillen with 231,015 shares. Separately, the company has retired $400,000 of debt, increased cash to over $14 million, and its subsidiary Spec…
Corcept Therapeutics Chief Executive Officer Joseph K. Belanoff sold 26,198 shares on March 25, 2026, generating about $1.3 million in proceeds under a Rule 10b5-1 plan. The company recently secured FDA approval for Lifyorli and received an analyst upgrade, even as its stock has fallen and a securities class action was filed.
Arteris, Inc. President and CEO K. Charles Janac executed two stock sales on March 25 and March 26, 2026, disposing of a combined 40,000 shares for about $731,623. The transactions followed a period of notable share-price appreciation. The company also reported fourth-quarter 2025 results that exceeded consensus estimates for both revenue and earni…
A Tecogen director purchased 10,000 shares on March 27, 2026, increasing her holdings to 260,416 shares. The trade occurred as the stock was trading near $2.57 and follows a quarter in which Tecogen missed earnings and revenue estimates. Market research notes suggest the stock may be undervalued and the company carries more cash than debt.
Legend Biotech Chief Executive Officer Huang Ying sold 9,936 ordinary shares on March 25, 2026, for roughly $87,138, according to an SEC Form 4. The sale occurred as the stock traded near a 52-week low, even after the company reported a revenue beat for the fourth quarter and full-year 2025 driven by Carvykti. Analysts issued a range of price targe…
U.S. stocks finished lower on Friday, with losses concentrated in Technology, Financials and Consumer Services. The Dow Jones Industrial Average dropped 1.72% to a fresh six-month low, while the S&P 500 and NASDAQ Composite also fell. Several large-cap names posted notable moves in both directions, volatility rose to a six-month high, and commodity…
The Dow Jones Industrial Average dropped 1.7% on Friday, confirming a correction after sliding 10% from its record close on February 10. The move comes as investors weigh the economic fallout from the U.S. and Israeli war with Iran, with surging oil prices and renewed inflation concerns shifting expectations for Federal Reserve policy.
Canadian equities closed modestly higher Friday, with the S&P/TSX Composite up 0.23% as strength in Materials, Energy and Clean Technology names outpaced losses elsewhere. Methanex, Strathcona Resources and I-80 Gold were the session's top performers, while Curaleaf, MDA and ATS Corporation led decliners. Market breadth favored losers, and measures…
Brazil's benchmark Bovespa closed down 0.64% in Sao Paulo as losses in Real Estate, Financials and Public Utilities led the market lower. Several individual names posted large percentage moves in both directions, Prio SA reached an all-time high, and option-implied volatility on the Bovespa climbed over 10%. Commodities saw notable gains for gold a…
TRG Latin America Acquisitions Corp. announced that its IPO underwriter exercised part of its over-allotment option, purchasing an additional 632,000 units at $10 each. This raises the total units sold to 20,632,000 and gross proceeds to over $206 million, strengthening the company's capital for future business combinations.
Eduard Grabscheid, chief financial officer of JFrog Ltd (NASDAQ: FROG), sold 9,043 ordinary shares on March 25, 2026, at $45.00 per share for proceeds of $406,935. The sale was made under a Rule 10b5-1 plan put in place May 16, 2025. After the transaction Grabscheid directly holds 224,796 shares. Separately, JFrog announced a new Agent Skills Regis…
RingCentral President and COO Kira Makagon disposed of 51,510 shares of Class A common stock across several transactions on March 26 and 27, 2026, generating roughly $1.8 million in proceeds. The trades were carried out under a Rule 10b5-1 plan adopted in March 2025. RingCentral reported modest fourth-quarter revenue growth, beat EPS expectations, …
JFrog Ltd director Sela Yossi sold 25,000 ordinary shares on March 25, 2026, realizing $1.13 million through multiple transactions executed between $45.00 and $45.32 per share. After the sale Yossi holds 103,922 shares. The transaction was carried out under a Rule 10b5-1 trading plan adopted on September 5, 2025. JFrog is trading near $43.34 with a…
